AAAAAA

   
Results: 1-18 |
Results: 18
V delta 1T lymphocytes expressing a Th1 phenotype are the major gamma delta T cell subset infiltrating the liver of HCV-infected persons
Authors: Agrati, C D'Offizi, G Narciso, P Abrignani, S Ippolito, G Colizzi, V Poccia, F
Citation: C. Agrati et al., V delta 1T lymphocytes expressing a Th1 phenotype are the major gamma delta T cell subset infiltrating the liver of HCV-infected persons, MOL MED, 7(1), 2001, pp. 11-19
CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs
Authors: Kitadokoro, K Bordo, D Galli, G Petracca, R Falugi, F Abrignani, S Grandi, G Bolognesi, M
Citation: K. Kitadokoro et al., CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs, EMBO J, 20(1-2), 2001, pp. 12-18
The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor
Authors: Masciopinto, F Campagnoli, S Abrignani, S Uematsu, Y Pileri, P
Citation: F. Masciopinto et al., The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor, VIRUS RES, 80(1-2), 2001, pp. 1-10
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs
Authors: Burioni, R Bugli, F Mancini, N Rosa, D Di Campli, C Moroncini, G Manzin, A Abrignani, S Varaldo, PE Clementi, M Fadda, G
Citation: R. Burioni et al., Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs, VIROLOGY, 288(1), 2001, pp. 29-35
Folding of hepatitis C virus E1 glycoprotein in a cell-free system
Authors: Merola, M Brazzoli, M Cocchiarella, F Heile, JM Helenius, A Weiner, AJ Houghton, M Abrignani, S
Citation: M. Merola et al., Folding of hepatitis C virus E1 glycoprotein in a cell-free system, J VIROLOGY, 75(22), 2001, pp. 11205-11217
Virus-specific CD8+ T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection
Authors: Prezzi, C Casciaro, MA Francavilla, V Schiaffella, E Finocchi, L Chircu, LV Bruno, G Sette, A Abrignani, S Barnaba, V
Citation: C. Prezzi et al., Virus-specific CD8+ T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection, EUR J IMMUN, 31(3), 2001, pp. 894-906
Binding of the hepatitis C virus envelope protein E2 to CB81 provides a co-stimulatory signal for human T cells
Authors: Wack, A Soldaini, E Tseng, CTK Nuti, S Kimpel, GR Abrignani, S
Citation: A. Wack et al., Binding of the hepatitis C virus envelope protein E2 to CB81 provides a co-stimulatory signal for human T cells, EUR J IMMUN, 31(1), 2001, pp. 166-175
Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C
Authors: Valiante, NM D'Andrea, A Crotta, S Lechner, F Klenerman, P Nuti, S Wack, A Abrignani, S
Citation: Nm. Valiante et al., Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C, IMMUNOL REV, 174, 2000, pp. 77-89
Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes
Authors: Hadlock, KG Lanford, RE Perkins, S Rowe, J Yang, Q Levy, S Pileri, P Abrignani, S Foung, SKH
Citation: Kg. Hadlock et al., Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes, J VIROLOGY, 74(22), 2000, pp. 10407-10416
Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates
Authors: Heile, JM Fong, YL Rosa, D Berger, K Saletti, G Campagnoli, S Bensi, G Capo, S Coates, S Crawford, K Dong, C Wininger, M Baker, C Cousens, L Chien, D Ng, P Archangel, P Grandi, G Houghton, M Abrignani, S
Citation: Jm. Heile et al., Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates, J VIROLOGY, 74(15), 2000, pp. 6885-6892
Structure-function analysis of hepatitis C virus envelope-CD81 binding
Authors: Petracca, R Falugi, F Galli, G Norais, N Rosa, D Campagnoli, S Burgio, V Di Stasio, E Giardina, B Houghton, M Abrignani, S Grandi, G
Citation: R. Petracca et al., Structure-function analysis of hepatitis C virus envelope-CD81 binding, J VIROLOGY, 74(10), 2000, pp. 4824-4830
Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81
Authors: Allander, T Drakenberg, K Beyene, A Rosa, D Abrignani, S Houghton, M Widell, A Grillner, L Persson, MAA
Citation: T. Allander et al., Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81, J GEN VIROL, 81, 2000, pp. 2451-2459
Neonatal invariant V alpha 24(+) NKT lymphocytes are activated memory cells
Authors: D'Andrea, A Goux, D De Lalla, C Koezuka, Y Montagna, D Moretta, A Dellabona, P Casorati, G Abrignani, S
Citation: A. D'Andrea et al., Neonatal invariant V alpha 24(+) NKT lymphocytes are activated memory cells, EUR J IMMUN, 30(6), 2000, pp. 1544-1550
Prophylaxis of hepatitis C with intramuscular immunoglobulin - Clinical and economic appraisal
Authors: Piazza, M Sagliocca, L Tosone, G Guadagnino, V Stazi, MA Orlando, R Borgia, G Rosa, D Abrignani, S Palumbo, F Manzin, A Clementi, M
Citation: M. Piazza et al., Prophylaxis of hepatitis C with intramuscular immunoglobulin - Clinical and economic appraisal, BIODRUGS, 12(4), 1999, pp. 291-300
Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice
Authors: Toneatto, S Finco, O van der Putten, H Abrignani, S Annunziata, P
Citation: S. Toneatto et al., Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice, AIDS, 13(17), 1999, pp. 2343-2348
EASL International Consensus Conference on Hepatitis C - Paris, 26-27 February 1999 - Consensus statement (Reprinted from Journal of Hematology, vol 30, pg 956-961, 1999)
Authors: Marcellin, P Alberti, A Dusheiko, G Esteban, R Manns, M Shouval, D Weiland, O Williams, R Benhamou, JP Rodes, J Alter, H Bismuth, H Desmet, V Guardia, J Heathcote, J Lok, A Maddrey, WC Zum Buschenfelde, KHM Pagliaro, L Paumgartner, G Sherlock, S Abrignani, S Alberti, A Alter, M Bonino, F Bortolotti, F Brechot, C de Moura, MC Carreno, V Colombo, M Craxi, A Davis, G De Francesco, R Degos, F Di Bisceglie, A Dienes, H Dusheiko, G Esteban, J Esteban, R Farci, P Ferrari, C Foster, G Hadziyannis, S Hoofnagle, J Koff, R Lavanchy, D Lindsay, K Lunel, F Manns, M Marcellin, P Mondelli, M Nalpas, B Naoumov, N Pawlotsky, JM Pol, S Pontisso, P Poynard, T Prieto, J Rizzetto, M Roggendorf, M Moreno, MR Samuel, D Sanchez-Tapias, J Schalm, S Shouval, D Simmonds, P Soriano, V Tassopoulos, N Thomas, H Trepo, C Van der Poel, CL Vogel, W Weiland, O Wejstal, R Williams, R Wright, T Zanetti, A Zarski, JP Zeuzem, S Zoulim, F
Citation: P. Marcellin et al., EASL International Consensus Conference on Hepatitis C - Paris, 26-27 February 1999 - Consensus statement (Reprinted from Journal of Hematology, vol 30, pg 956-961, 1999), J HEPATOL, 31, 1999, pp. 3-8
Perspectives for a vaccine against hepatitis C virus
Authors: Abrignani, S Houghton, M Hsu, HH
Citation: S. Abrignani et al., Perspectives for a vaccine against hepatitis C virus, J HEPATOL, 31, 1999, pp. 259-263
Presence of effector CD8(+) T cells in hepatitis C virus-exposed healthy seronegative donors
Authors: Scognamiglio, P Accapezzato, D Casciaro, MA Cacciani, A Artini, M Bruno, G Chircu, ML Sidney, J Southwood, S Abrignani, S Sette, A Barnaba, V
Citation: P. Scognamiglio et al., Presence of effector CD8(+) T cells in hepatitis C virus-exposed healthy seronegative donors, J IMMUNOL, 162(11), 1999, pp. 6681-6689
Risultati: 1-18 |